MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Clinical trial NCT02137759 · UNKNOWN

Trial details

NCT number: NCT02137759
Sponsor: Emory University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme of Brain

Start date: 2014-05-07
Primary completion: 2023-08-15
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.